DUBLIN, Jan. 6, 2015 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at the Westin St. Francis Hotel in San Francisco, CA. Interested parties can access the presentation, which is scheduled to begin at 8:00 AM PST at http://perrigo.investorroom.com/events-webcasts.
From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquartered in Ireland, has grown to become a leading global healthcare supplier. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products and active pharmaceutical ingredients (API), and receives royalties from Multiple Sclerosis drug Tysabri®. The Company is the world's largest manufacturer of OTC healthcare products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo's mission is to offer uncompromised "Quality Affordable Healthcare Products®" and it does so across a wide variety of product categories primarily in the United States, United Kingdom, Mexico, Israel and Australia, as well as more than 40 other key markets worldwide, including Canada, China and Latin America. Visit Perrigo on the Internet (http://www.perrigo.com).
Logo - http://photos.prnewswire.com/prnh/20120301/DE62255LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/perrigo-company-to-present-at-the-33rd-annual-jp-morgan-healthcare-conference-300016487.html
SOURCE Perrigo Company plc